Welcome to this continuing professional development feature. This feature looks at the key aspects of the ‘triple therapy’ inhaler Trelegy Ellipta. We have summarised the key features of the new inhaler and presented the information in a concise way. With so many new inhalers on the market, there certainly is a need to keep up to date with the new inhalers such as this one.
Please note this module summarises the relevant clinical particulars of Trelegy Ellipta but does not cover inhaler technique. We will cover that in a future module. Patients should be repeatedly coached on how to use their inhalers properly.
You might want to ask yourself the following questions to identify any learning needs.
- What are the ingredients in Trelegy Ellipta?
- What is the mechanism of action of each ingredient?
- What are the indications for Trelegy Ellipta?
- Are there any special precautions for prescribing?
- What are the clinically significant interactions of Trelegy Ellipta?
- Is Trelegy Ellipta safe to use in pregnancy or breastfeeding?
- Do you know about the adverse effects of Trelegy Ellipta?
- Is Trelegy Ellipta safe to use in the elderly and other special populations?
There is a CPD quiz at the end to confirm you have taken part in, and successfully completed the activity. If you complete the quiz you will receive an email with your results and feedback on any questions you got wrong.
We hope you find the feature useful and would welcome any feedback you may have. There is an opportunity to give feedback before completing the quiz at the end. This feedback will be used to inform future topics and also to refine the feature.
Disclaimer: None of the content here may be reproduced. The rights to the content sit with Pharmacy in Practice. In any medical field, information is updated over time. Procedures and practices, therefore, will inevitably change too. The authors and reviewers have made every effort to make sure information within these modules is both up to date at the time of publication and accurate also. It is the responsibility of the healthcare professional to make informed professional decisions. The information should also be used in the context of local guidance. Pharmacy in Practice. can take no responsibility for any prescribing errors that may happen. Where drug dosing is concerned we advise readers to consult the BNF or the summary of product characteristics for the particular drug.